Duration of treatment with 5-aminosalicylic acid compounds

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

316

HTML

2117

Figures (1-1)

201

Sum=2634

Aug 28, 2007 (publication date) through Nov 12, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 28, 2007; 13(32): 4310-4315
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4310

Figure 1 Relapse rates amongst patients with ulcerative colitis in remission in a study of delayed release mesalazine compared with placebo[14]

Citation: Moshkovska T, Mayberry J. Duration of treatment with 5-aminosalicylic acid compounds. World J Gastroenterol 2007; 13(32): 4310-4315
URL: https://www.wjgnet.com/1007-9327/full/v13/i32/4310.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i32.4310